Cargando…
SUN-181 Case Report: Rare Complication of SGLT2 Inhibitors Can Occur Only 10 Days after Starting the Medication
Introduction: Fournier’s gangrene is an extremely rare infection that can occur in diabetic patients. The FDA recently issued a warning about patients taking sodium-glucose cotransporter-2 inhibitors stating that these patients are liable to develop Fournier gangrene. This complication usually occur...
Autores principales: | Elshimy, Ghada, Alhakim, Manal, Avechuco, Karina, Jyothinagaram, Sathya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552817/ http://dx.doi.org/10.1210/js.2019-SUN-181 |
Ejemplares similares
-
SUN-693 What Else Should Be Done in Patients with Uncontrolled Type 2 Diabetes and Severe Insulin Allergy?
por: Elshimy, Ghada, et al.
Publicado: (2020) -
SUN-177 House Of Carbs: The Path To Euglycemic Dka In Patients With Diabetes On Sglt2 Inhibitors
por: Islam, Julie, et al.
Publicado: (2019) -
Early Presentation of a Rare Complication of Sodium-Glucose Cotransporter-2 Inhibitors 10 Days After Initiation: Case Report and Literature Review
por: Elshimy, Ghada, et al.
Publicado: (2019) -
SUN-180 Successful Use of SGLT-2 Inhibitor Dapagliflozin in Three Patients with Renal Transplant and Diabetes: A Fruit for Thoughts
por: Elhadd, Tarik, et al.
Publicado: (2019) -
SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?
por: Zayas, Francisco, et al.
Publicado: (2019)